Healthcare quality in systemic lupus erythematosus: Using Donabedian's conceptual framework to understand what we know

International Journal of Clinical Rheumatology

Volumn 7, Issue 1, 2012, Pages 95-107

  Lawson, Erica F ^a   Yazdany, Jinoos ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

access to care; health disparities; health outcomes; healthcare quality; systemic lupus erythematosus

Indexed keywords

HYDROXYCHLOROQUINE;

CLINICAL ASSESSMENT; CONCEPTUAL FRAMEWORK; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH DISPARITY; HOSPITAL SERVICE; HUMAN; KIDNEY FAILURE; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT MONITORING; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; SOCIAL STATUS; SYSTEMIC LUPUS ERYTHEMATOSUS; TOTAL QUALITY MANAGEMENT;

EID: 84856688002     PISSN: 17584272     EISSN: 17584280     Source Type: Journal    
DOI: 10.2217/ijr.11.65     Document Type: Review

References (40)

1. Donabedian A. The quality of care. How can it be assessed? JAMA 260(12), 1743-1748 (1988).
2. Peikes D, Chen A, Schore J, Brown R. Effects of care coordination on hospitalization, quality of care, and health care expenditures among medicare beneficiaries: 15 randomized trials. JAMA 301(6), 603-618 (2009).
3. Ward MM. Association between physician volume and in-hospital mortality in patients with systemic lupus erythematosus. Arthrit. Rheum. 52(6), 1646-1654 (2005). (Pubitemid 40852871)
4. Tonner C, Trupin L, Yazdany J, Criswell L, Katz P, Yelin E. Role of community and individual characteristics in physician visits for persons with systemic lupus erythematosus. Arthrit. Care Res. (Hoboken) 62(6), 888-895 (2010).
5. Yazdany J, Gillis JZ, Trupin L et al. Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus. Arthrit. Rheum. 57(4), 593-600 (2007). (Pubitemid 46764048)
6. Gillis JZ, Yazdany J, Trupin L et al. Medicaid and access to care among persons with systemic lupus erythematosus. Arthrit. Rheum. 57(4), 601-607 (2007). (Pubitemid 46764049)
7. Ward MM. Medical insurance, socioeconomic status, and age of onset of endstage renal disease in patients with lupus nephritis. J. Rheumatol. 34(10), 2024-2027 (2007). (Pubitemid 47548205)
8. Ward MM. Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus. J. Rheumatol. 37(6), 1158-1163 (2010).
9. Yelin E, Trupin L, Katz P et al. Impact of health maintenance organizations and fee-for-service on health care utilization among people with systemic lupus erythematosus. Arthrit. Rheum. 57(3), 508-515 (2007). (Pubitemid 46682541)
10. Billings J, Zeitel L, Lukomnik J, Carey TS, Blank AE, Newman L. Impact of socioeconomic status on hospital use in New York city. Health Aff. (Millwood) 12(1), 162-173 (1993). (Pubitemid 23159140)
11. Weissman JS, Gatsonis C, Epstein AM. Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland. JAMA 268(17), 2388-2394 (1992).
12. Ward MM. Avoidable hospitalizations in patients with systemic lupus erythematosus. Arthrit. Rheum. 59(2), 162-168 (2008). (Pubitemid 351272949)
13. Hiraki LT, Lu B, Alexander SR et al. End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. Arthrit. Rheum. 63(7), 1988-1997 (2011).
14. Ward MM. Hospital experience and mortality in patients with systemic lupus erythematosus. Arthrit. Rheum. 42(5), 891-898 (1999). (Pubitemid 29214999)
15. Ward MM. Education level and mortality in systemic lupus erythematosus (SLE): evidence of underascertainment of deaths due to SLE in ethnic minorities with low education levels. Arthrit. Rheum. 51(4), 616-624 (2004). (Pubitemid 39056251)
16. Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Research methods used in developing and applying quality indicators in primary care. BMJ 326(7393), 816-819 (2003). (Pubitemid 36523598)
17. Yazdany J, Panopalis P, Gillis JZ et al. A quality indicator set for systemic lupus erythematosus. Arthrit. Rheum. 61(3), 370-377 (2009).
18. Brook RH. The RAND/UCLA appropriateness method. In: Methodology Perspectives. McCormick KA, Moore SR, Siegel RA (Eds). US Department of Health and Human Services, Rockville, MD, USA, 59-70 (1994).
19. Mosca M, Tani C, Aringer M et al. Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. Autoimmun. Rev. 10(7), 383-388 (2011).
20. Yazdany J, Trupin L, Kaiser R et al. Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality? Arthrit. Care Res. (Hoboken) doi:10.1002/acr.20402 (2010) (Epub ahead of print).
21. Yazdany J, Tonner C, Trupin L et al. Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study. Arthrit. Res. Ther. 12(3), R84 (2010).
22. Demas KL, Keenan BT, Solomon DH, Yazdany J, Costenbader KH. Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators. Semin. Arthrit. Rheum. 40(3), 193-200 (2010).
23. Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopolis P, Yazdany J. Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Arthrit. Care Res. (Hoboken) 62(7), 993-1001 (2010).
24. Tsakonas E, Joseph L, Esdaile JM et al. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus 7(2), 80-85 (1998). (Pubitemid 28107971)
25. Levy RA, Vilela VS, Cataldo MJ et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10(6), 401-404 (2001). (Pubitemid 32578614)
26. Alarcon GS, McGwin G, Bertoli AM et al. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann. Rheum. Dis. 66(9), 1168-1172 (2007). (Pubitemid 47309732)
27. Fessler BJ, Alarcon GS, Mcgwin G Jr et al. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthrit. Rheum. 52(5), 1473-1480 (2005). (Pubitemid 40663939)
28. Ruiz-Irastorza G, Egurbide MV, Pijoan JI et al. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 15(9), 577-583 (2006). (Pubitemid 44661744)
29. Schmajuk G, Yazdany J, Trupin L, Yelin E. Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus. Arthrit. Care Res. (Hoboken) 62(3), 386-392 (2010).
30. Ward MM. Laboratory abnormalities at the onset of treatment of end-stage renal disease: are there racial or socioeconomic disparities in care? Arch. Intern. Med. 167(10), 1083-1091 (2007). (Pubitemid 46835797)
31. Trivedi AN, Grebla RC, Wright SM, Washington DL. Despite improved quality of care in the Veterans Affairs health system, racial disparity persists for important clinical outcomes. Health Aff. (Millwood) 30(4), 707-715 (2011).
32. Grossman JM, Gordon R, Ranganath VK et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthrit. Care Res. (Hoboken) 62(11), 1515-1526 (2010).
33. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am. J. Med. 91(4), 345-353 (1991).
34. Mosley-Williams A, Lumley MA, Gillis M, Leisen J, Guice D. Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthrit. Rheum. 47(6), 630-638 (2002). (Pubitemid 35461316)
35. Daleboudt GM, Broadbent E, McQueen F, Kaptein AA. Intentional and unintentional treatment non-adherence in patients with systemic lupus erythematosus. Arthrit. Care Res. (Hoboken) doi:10.1002/acr.20411 (2010) (Epub ahead of print).
36. Porter ME. What is value in health care? N. Engl. J. Med. 363(26), 2477-2481 (2010).
37. Langley GN, Moen R, Nolan KM et al. The Improvement Guide: A Practical Approach To Enhancing Organizational Performance. Jossey-Bass Publishers, San Francisco, CA, USA (1996).
38. Al-Hoqail R, Al-Shlash S, Helmi A et al. Total quality management in plastic surgery. J. Craniofac. Surg. 21(1), 10-19 (2010).
39. Chen AH, Kushel MB, Grumbach K, Yee HF Jr. Practice profile. A safety-net system gains efficiencies through "eReferrals" to specialists. Health Aff. (Millwood) 29(5), 969-971 (2010).
40. Harrington JT, Lease J. System-based coordination of postfracture osteoporosis care compared with traditional approaches. Arthrit. Care Res. (Hoboken) 62(11), 1646-1649 (2010).